Back to articles

Elderly Patients with Heart Failure: ACE Inhibitors Preferred over Angiotensin II Blockers


Recently completed studies of elderly patients with congestive heart failure show no difference in effectiveness between the ACE inhibitor captopril (Capoten—Bristol-Myers Squibb) and the angiotensin II antagonist losartan (Cozaar—Merck). Unless patients are intolerant of the side effects of ACE inhibitors, these established agents remain the treatment of first choice.


Pitt B et al. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747–52.

Anonymous. ELITE II. Clin Cardiol Alert. 1999;18(12):91.

Davies MK et al. ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates. BMJ. 2000;320:428 ff.

Song JC, White CM. Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists. Pharmacotherapy. 2000;20:130–9.